219 related articles for article (PubMed ID: 25779879)
1. Losartan increases bone mass and accelerates chondrocyte hypertrophy in developing skeleton.
Chen S; Grover M; Sibai T; Black J; Rianon N; Rajagopal A; Munivez E; Bertin T; Dawson B; Chen Y; Jiang MM; Lee B; Yang T; Bae Y
Mol Genet Metab; 2015 May; 115(1):53-60. PubMed ID: 25779879
[TBL] [Abstract][Full Text] [Related]
2. Liver X Receptor activation delays chondrocyte hypertrophy during endochondral bone growth.
Sun MM; Beier F
Osteoarthritis Cartilage; 2014 Jul; 22(7):996-1006. PubMed ID: 24852699
[TBL] [Abstract][Full Text] [Related]
3. ERK1 and ERK2 regulate chondrocyte terminal differentiation during endochondral bone formation.
Chen Z; Yue SX; Zhou G; Greenfield EM; Murakami S
J Bone Miner Res; 2015 May; 30(5):765-74. PubMed ID: 25401279
[TBL] [Abstract][Full Text] [Related]
4. 8-Nitro-cGMP promotes bone growth through expansion of growth plate cartilage.
Hoshino M; Kaneko K; Miyamoto Y; Yoshimura K; Suzuki D; Akaike T; Sawa T; Ida T; Fujii S; Ihara H; Tanaka J; Tsukuura R; Chikazu D; Mishima K; Baba K; Kamijo R
Free Radic Biol Med; 2017 Sep; 110():63-71. PubMed ID: 28559051
[TBL] [Abstract][Full Text] [Related]
5. RARγ is a negative regulator of osteoclastogenesis.
Green AC; Poulton IJ; Vrahnas C; Häusler KD; Walkley CR; Wu JY; Martin TJ; Gillespie MT; Chandraratna RA; Quinn JM; Sims NA; Purton LE
J Steroid Biochem Mol Biol; 2015 Jun; 150():46-53. PubMed ID: 25800721
[TBL] [Abstract][Full Text] [Related]
6. The critical role of the epidermal growth factor receptor in endochondral ossification.
Zhang X; Siclari VA; Lan S; Zhu J; Koyama E; Dupuis HL; Enomoto-Iwamoto M; Beier F; Qin L
J Bone Miner Res; 2011 Nov; 26(11):2622-33. PubMed ID: 21887704
[TBL] [Abstract][Full Text] [Related]
7. SIK3 is essential for chondrocyte hypertrophy during skeletal development in mice.
Sasagawa S; Takemori H; Uebi T; Ikegami D; Hiramatsu K; Ikegawa S; Yoshikawa H; Tsumaki N
Development; 2012 Mar; 139(6):1153-63. PubMed ID: 22318228
[TBL] [Abstract][Full Text] [Related]
8. Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone.
Harada S; Mizoguchi T; Kobayashi Y; Nakamichi Y; Takeda S; Sakai S; Takahashi F; Saito H; Yasuda H; Udagawa N; Suda T; Takahashi N
J Bone Miner Res; 2012 Feb; 27(2):461-73. PubMed ID: 22052469
[TBL] [Abstract][Full Text] [Related]
9. Beclin1 Modulates Bone Homeostasis by Regulating Osteoclast and Chondrocyte Differentiation.
Arai A; Kim S; Goldshteyn V; Kim T; Park NH; Wang CY; Kim RH
J Bone Miner Res; 2019 Sep; 34(9):1753-1766. PubMed ID: 31074883
[TBL] [Abstract][Full Text] [Related]
10. Differential responses of bone to angiotensin II and angiotensin(1-7): beneficial effects of ANG(1-7) on bone with exposure to high glucose.
Sha NN; Zhang JL; Poon CC; Li WX; Li Y; Wang YF; Shi W; Lin FH; Lin WP; Wang YJ; Zhang Y
Am J Physiol Endocrinol Metab; 2021 Jan; 320(1):E55-E70. PubMed ID: 33103451
[TBL] [Abstract][Full Text] [Related]
11. META060 inhibits osteoclastogenesis and matrix metalloproteinases in vitro and reduces bone and cartilage degradation in a mouse model of rheumatoid arthritis.
Konda VR; Desai A; Darland G; Bland JS; Tripp ML
Arthritis Rheum; 2010 Jun; 62(6):1683-92. PubMed ID: 20201075
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of apoptosis signal-regulating kinase 1 enhances endochondral bone formation by increasing chondrocyte survival.
Eaton GJ; Zhang QS; Diallo C; Matsuzawa A; Ichijo H; Steinbeck MJ; Freeman TA
Cell Death Dis; 2014 Nov; 5(11):e1522. PubMed ID: 25393478
[TBL] [Abstract][Full Text] [Related]
13. Infant cynomolgus monkeys exposed to denosumab in utero exhibit an osteoclast-poor osteopetrotic-like skeletal phenotype at birth and in the early postnatal period.
Boyce RW; Varela A; Chouinard L; Bussiere JL; Chellman GJ; Ominsky MS; Pyrah IT
Bone; 2014 Jul; 64():314-25. PubMed ID: 24727159
[TBL] [Abstract][Full Text] [Related]
14. Deletion of beta catenin in hypertrophic growth plate chondrocytes impairs trabecular bone formation.
Golovchenko S; Hattori T; Hartmann C; Gebhardt M; Gebhard S; Hess A; Pausch F; Schlund B; von der Mark K
Bone; 2013 Jul; 55(1):102-12. PubMed ID: 23567158
[TBL] [Abstract][Full Text] [Related]
15. Extracellular signal-regulated kinase 1 (ERK1) and ERK2 play essential roles in osteoblast differentiation and in supporting osteoclastogenesis.
Matsushita T; Chan YY; Kawanami A; Balmes G; Landreth GE; Murakami S
Mol Cell Biol; 2009 Nov; 29(21):5843-57. PubMed ID: 19737917
[TBL] [Abstract][Full Text] [Related]
16. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
17. Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase/Akt and Erk pathways in association with signaling Adaptor DAP12.
Kameda Y; Takahata M; Komatsu M; Mikuni S; Hatakeyama S; Shimizu T; Angata T; Kinjo M; Minami A; Iwasaki N
J Bone Miner Res; 2013 Dec; 28(12):2463-75. PubMed ID: 23677868
[TBL] [Abstract][Full Text] [Related]
18. Raf Kinases Are Essential for Phosphate Induction of ERK1/2 Phosphorylation in Hypertrophic Chondrocytes and Normal Endochondral Bone Development.
Papaioannou G; Petit ET; Liu ES; Baccarini M; Pritchard C; Demay MB
J Biol Chem; 2017 Feb; 292(8):3164-3171. PubMed ID: 28073913
[TBL] [Abstract][Full Text] [Related]
19. Modulation of endochondral ossification by MEK inhibitors PD0325901 and AZD6244 (Selumetinib).
El-Hoss J; Kolind M; Jackson MT; Deo N; Mikulec K; McDonald MM; Little CB; Little DG; Schindeler A
Bone; 2014 Feb; 59():151-61. PubMed ID: 24269278
[TBL] [Abstract][Full Text] [Related]
20. The natural flavonoid galangin inhibits osteoclastic bone destruction and osteoclastogenesis by suppressing NF-κB in collagen-induced arthritis and bone marrow-derived macrophages.
Huh JE; Jung IT; Choi J; Baek YH; Lee JD; Park DS; Choi DY
Eur J Pharmacol; 2013 Jan; 698(1-3):57-66. PubMed ID: 22985747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
